Enlivex Ltd (ENLV) Implied Volatility Current

Tracking ENLV implied volatility helps you identify when options premiums on Enlivex Ltd are historically cheap or expensive, and where the best trades are hiding. Enlivex Ltd implied volatility reflects the market's expectation of future price movement: when ENLV IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Enlivex Ltd's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ENLV, tracking metrics like ENLV IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ENLV signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ENLV implied volatility sits today versus where it has been. Our scanner ranks Enlivex Ltd implied volatility against its historical range, surfaces extremes in ENLV IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Enlivex Ltd IV is rich or cheap — measure it, then act on it.